vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and SHORE BANCSHARES INC (SHBI). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $59.1M, roughly 1.1× SHORE BANCSHARES INC). On growth, SHORE BANCSHARES INC posted the faster year-over-year revenue change (11.8% vs 8.1%). SHORE BANCSHARES INC produced more free cash flow last quarter ($59.2M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 11.3%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Shore Bancshares Inc. is a U.S. regional bank holding company headquartered in Maryland. It offers a full range of retail and commercial banking services, including deposit products, personal and commercial loans, and wealth management solutions, primarily serving local individual customers, small businesses and mid-sized enterprises in its operating regions.
CTKB vs SHBI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $59.1M |
| Net Profit | $-44.1M | — |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | 35.2% |
| Net Margin | -70.9% | — |
| Revenue YoY | 8.1% | 11.8% |
| Net Profit YoY | -557.1% | — |
| EPS (diluted) | — | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $59.1M | ||
| Q3 25 | $52.3M | $56.4M | ||
| Q2 25 | $45.6M | $56.6M | ||
| Q1 25 | $41.5M | $53.0M | ||
| Q4 24 | $57.5M | $52.9M | ||
| Q3 24 | $51.5M | $50.5M | ||
| Q2 24 | $46.6M | $50.6M | ||
| Q1 24 | $44.9M | $47.7M |
| Q4 25 | $-44.1M | — | ||
| Q3 25 | $-5.5M | $14.3M | ||
| Q2 25 | $-5.6M | $15.5M | ||
| Q1 25 | $-11.4M | $13.8M | ||
| Q4 24 | $9.6M | — | ||
| Q3 24 | $941.0K | $11.2M | ||
| Q2 24 | $-10.4M | $11.2M | ||
| Q1 24 | $-6.2M | $8.2M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | 35.2% | ||
| Q3 25 | -17.6% | 33.7% | ||
| Q2 25 | -23.3% | 36.5% | ||
| Q1 25 | -36.1% | 34.4% | ||
| Q4 24 | 5.2% | 34.3% | ||
| Q3 24 | -8.2% | 29.6% | ||
| Q2 24 | -18.3% | 29.7% | ||
| Q1 24 | -23.9% | 22.2% |
| Q4 25 | -70.9% | — | ||
| Q3 25 | -10.5% | 25.5% | ||
| Q2 25 | -12.2% | 27.4% | ||
| Q1 25 | -27.5% | 26.0% | ||
| Q4 24 | 16.8% | — | ||
| Q3 24 | 1.8% | 22.1% | ||
| Q2 24 | -22.4% | 22.2% | ||
| Q1 24 | -13.8% | 17.2% |
| Q4 25 | — | $0.48 | ||
| Q3 25 | — | $0.43 | ||
| Q2 25 | — | $0.46 | ||
| Q1 25 | — | $0.41 | ||
| Q4 24 | — | $0.39 | ||
| Q3 24 | — | $0.34 | ||
| Q2 24 | — | $0.34 | ||
| Q1 24 | — | $0.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $355.6M |
| Total DebtLower is stronger | — | $89.1M |
| Stockholders' EquityBook value | $341.7M | $589.9M |
| Total Assets | $461.5M | $6.3B |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $355.6M | ||
| Q3 25 | $93.3M | $416.5M | ||
| Q2 25 | $75.5M | $185.0M | ||
| Q1 25 | $95.3M | $389.0M | ||
| Q4 24 | $98.7M | $459.9M | ||
| Q3 24 | $162.3M | $183.6M | ||
| Q2 24 | $177.9M | $138.9M | ||
| Q1 24 | $168.8M | $114.6M |
| Q4 25 | — | $89.1M | ||
| Q3 25 | — | $74.5M | ||
| Q2 25 | — | $74.2M | ||
| Q1 25 | — | $74.0M | ||
| Q4 24 | — | $73.7M | ||
| Q3 24 | — | $123.5M | ||
| Q2 24 | — | $122.8M | ||
| Q1 24 | — | $72.6M |
| Q4 25 | $341.7M | $589.9M | ||
| Q3 25 | $378.6M | $577.2M | ||
| Q2 25 | $377.6M | $565.2M | ||
| Q1 25 | $379.6M | $552.5M | ||
| Q4 24 | $395.7M | $541.1M | ||
| Q3 24 | $385.5M | $533.3M | ||
| Q2 24 | $389.1M | $522.8M | ||
| Q1 24 | $392.6M | $515.2M |
| Q4 25 | $461.5M | $6.3B | ||
| Q3 25 | $494.9M | $6.3B | ||
| Q2 25 | $493.3M | $6.0B | ||
| Q1 25 | $482.6M | $6.2B | ||
| Q4 24 | $499.5M | $6.2B | ||
| Q3 24 | $491.2M | $5.9B | ||
| Q2 24 | $483.7M | $5.9B | ||
| Q1 24 | $492.1M | $5.8B |
| Q4 25 | — | 0.15× | ||
| Q3 25 | — | 0.13× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.23× | ||
| Q1 24 | — | 0.14× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $62.4M |
| Free Cash FlowOCF − Capex | $-1.8M | $59.2M |
| FCF MarginFCF / Revenue | -2.9% | 100.2% |
| Capex IntensityCapex / Revenue | 1.6% | 5.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $110.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $62.4M | ||
| Q3 25 | $-3.9M | $42.5M | ||
| Q2 25 | $108.0K | $-8.3M | ||
| Q1 25 | $-125.0K | $19.8M | ||
| Q4 24 | $2.0M | $46.9M | ||
| Q3 24 | $13.2M | $9.1M | ||
| Q2 24 | $6.2M | $3.0M | ||
| Q1 24 | $4.0M | $2.4M |
| Q4 25 | $-1.8M | $59.2M | ||
| Q3 25 | $-4.6M | $41.9M | ||
| Q2 25 | $-1.5M | $-9.2M | ||
| Q1 25 | $-974.0K | $18.8M | ||
| Q4 24 | $1.1M | $41.7M | ||
| Q3 24 | $12.2M | $8.4M | ||
| Q2 24 | $5.2M | $1.4M | ||
| Q1 24 | $3.4M | $614.0K |
| Q4 25 | -2.9% | 100.2% | ||
| Q3 25 | -8.7% | 74.3% | ||
| Q2 25 | -3.2% | -16.3% | ||
| Q1 25 | -2.3% | 35.4% | ||
| Q4 24 | 1.9% | 78.8% | ||
| Q3 24 | 23.7% | 16.7% | ||
| Q2 24 | 11.0% | 2.9% | ||
| Q1 24 | 7.6% | 1.3% |
| Q4 25 | 1.6% | 5.4% | ||
| Q3 25 | 1.3% | 1.0% | ||
| Q2 25 | 3.5% | 1.6% | ||
| Q1 25 | 2.0% | 1.9% | ||
| Q4 24 | 1.6% | 9.9% | ||
| Q3 24 | 2.0% | 1.2% | ||
| Q2 24 | 2.3% | 3.1% | ||
| Q1 24 | 1.3% | 3.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | 2.96× | ||
| Q2 25 | — | -0.54× | ||
| Q1 25 | — | 1.44× | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | 0.81× | ||
| Q2 24 | — | 0.27× | ||
| Q1 24 | — | 0.29× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
SHBI
Segment breakdown not available.
